Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

September 28 - 30, 2016
Marriott Marquis Times Square,
New York, NY

Capitalize on Exclusive Insights to Accelerate Innovation and Demonstrate Value

The only strategic-level conference that brings together the industry thought leaders to share, discuss and resolve fundamental challenges in biopharma

Thank you to everyone who attended PSA: The Pharmaceutical Strategy Conference 2016! Sign up for updates for our event in 2017!

Benchmark Yourself Against the Competition

Mergers & Acquisitions

Investor Keynote: Besting a Bio Bubble: What Private Biotech did to Beat the Last Bear market   

  •  Sandra J. Wrobel, Partner and Managing Director, Strategic Decisions Group (SDG)
Research & Development

R&D Panel: Breaking Through in Alzheimer’s

  • Martin Tolar, MD, PhD – Founder, President & CEO, Alzheon, Inc.
  •  Susan Rosenbaum, J. D., Chairman & Chief Executive Officer, Lauren Sciences LLC
Commercial Business Models

Keynote: How Can Life Science Companies Distinguish Themselves in the New Health Economy?

  •  Richard C. Edmunds, Global Practice Lead for Life Sciences Strategy Group, PwC
Reimbursement

Reimbursement/Market Access Panel: The Road to Value-Based Drug Pricing

  • Edmund Pezalla, MD, MPH, VP, National Medical Director, Pharmacy Policy & Strategy, Aetna
  • Richard C. Ascroft, RPh, JD, Vice President, Managed Markets and Government Affairs, Takeda Pharmaceuticals
  •  Cameron Durrant, MD, Chairman and CEO, KaloBios Pharmaceuticals Inc.
Drug Pricing

Keynote Address: Big Debate on Drug-Pricing

  • Ron Cohen, CEO, Acorda Therapeutics
Deal Making Insights

Technology Platform Panel: Innovation in Early-Stage Deal Making

  • Paulette Dillon, SVP of Corporate Development, Atreca Inc.
  • Sree KantHead of Strategy – External R&D Innovation, Worldwide Research and Development, Pfizer
  • Nouhad Husseini, Vice President, Business Development, Regeneron
  • Karen Akinsanya, Ph.D., Head, Early Stage Assessment, North America, Business Development & Licensing, Merck & Co.
  • Pierre Gosselin, VP, Corporate Development, REGENXBIO

Gain access to intimate networking and honest dialogue with biopharma's top strategic leaders

Gain Insights into the Industry’s Hottest Trends
  • R&D Innovation
  • The Future of Primary Care Markets
  • Confronting Pharma’s Reputation Problem
  • Biotech’s Cycle-Proof Venture Investing Strategies
  • Innovation in Early-Stage Deal Making
  • The Road to Value-Based Drug Pricing
  • Rare Disease Drug Development
  • Digital Medicine
  • Reimbursement and Market Access
Gain Access to Senior Thought Leaders and Influencers in Biopharma
  • 5 + Hours of dedicated networking time to rub shoulders with CEO’s and other senior thought leaders from pharma, biotech and the payer communities.
  • 7 + Hours of strategically curated content to help you benchmark your business strategies against leaders in the industry
Discover the Next Big Thing in Pharma

Gain insights into early pipeline and take conversations off-stage with some of the industry's biggest names

Join us now!